Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (201-210 of 263) with videos related to

Pageof 27
Sort By:
Gut|January 2, 2023
Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate targetEloi R Verrier, Gaëtan Ligat, Laura Heydmann, et al.
Hepatology (Baltimore, Md.)|March 16, 2026
Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazoleNevena Slović, Sumit Mishra, Subhojit Paul, et al.
Cell Reports|March 17, 2015
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor RegressionJulien Fitamant, Filippos Kottakis, Samira Benhamouche, et al.
Journal of Proteome Research|July 9, 2024
The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular CarcinomaJade K Macdonald, Harrison B Taylor, Mengjun Wang, et al.
JHEP Reports : Innovation in Hepatology|March 29, 2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Nature Communications|January 23, 2015
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinomaDaniela Sia, Bojan Losic, Agrin Moeini, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 30, 2022
Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in LiverMozhdeh Sojoodi, Derek J Erstad, Stephen C Barrett, et al.
Nature Communications|June 3, 2020
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factorCarla Eller, Laura Heydmann, Che C Colpitts, et al.
The Journal of Clinical Investigation|April 5, 2022
Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitisSatoshi Kawamura, Yuki Matsushita, Shigeyuki Kurosaki, et al.
Gastroenterology|January 9, 2013
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomesDaniela Sia, Yujin Hoshida, Augusto Villanueva, et al.
Pageof 27

Showing results (201-210 of 263) with videos related to

Sort By:
Pageof 27
Gut|January 2, 2023
Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate targetEloi R Verrier, Gaëtan Ligat, Laura Heydmann, et al.
Hepatology (Baltimore, Md.)|March 16, 2026
Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazoleNevena Slović, Sumit Mishra, Subhojit Paul, et al.
Cell Reports|March 17, 2015
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor RegressionJulien Fitamant, Filippos Kottakis, Samira Benhamouche, et al.
Journal of Proteome Research|July 9, 2024
The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular CarcinomaJade K Macdonald, Harrison B Taylor, Mengjun Wang, et al.
JHEP Reports : Innovation in Hepatology|March 29, 2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Nature Communications|January 23, 2015
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinomaDaniela Sia, Bojan Losic, Agrin Moeini, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 30, 2022
Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in LiverMozhdeh Sojoodi, Derek J Erstad, Stephen C Barrett, et al.
Nature Communications|June 3, 2020
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factorCarla Eller, Laura Heydmann, Che C Colpitts, et al.
The Journal of Clinical Investigation|April 5, 2022
Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitisSatoshi Kawamura, Yuki Matsushita, Shigeyuki Kurosaki, et al.
Gastroenterology|January 9, 2013
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomesDaniela Sia, Yujin Hoshida, Augusto Villanueva, et al.
Pageof 27